U.S. flag

An official website of the United States government

GTR Home > Laboratories > GenepoweRx

GenepoweRx

  • GenepoweRx
  • Uppaluri K&H Personalized Medicine Clinic
  • Department: Clinical Genomics
  • plot no 240, suite 2B, road no 36, Jubilee hills, Hyderabad
  • Hyderabad, India 500104
  • Phone: +919502222300
    Email: rajitha@khdreamlife.com
  • Website: http://www.genepowerx.com

GTR Lab ID: 508562, Last updated:2024-07-01

Personnel

Conditions and tests

  • Atrial fibrillation, familial, 11 test
  • Atrial fibrillation, familial, 101 test
  • Atrial fibrillation, familial, 111 test
  • Atrial fibrillation, familial, 121 test
  • Atrial fibrillation, familial, 131 test
  • Atrial fibrillation, familial, 141 test
  • Atrial fibrillation, familial, 151 test
  • Atrial fibrillation, familial, 181 test
  • Atrial fibrillation, familial, 21 test
  • Atrial fibrillation, familial, 31 test
  • Atrial fibrillation, familial, 41 test
  • Atrial fibrillation, familial, 51 test
  • Atrial fibrillation, familial, 61 test
  • Atrial fibrillation, familial, 71 test
  • Atrial fibrillation, familial, 81 test
  • Atrial fibrillation, familial, 91 test
  • Autosomal dominant nonsyndromic hearing loss 221 test
  • Brugada syndrome 11 test
  • Brugada syndrome 21 test
  • Brugada syndrome 31 test
  • Brugada syndrome 41 test
  • Brugada syndrome 51 test
  • Brugada syndrome 61 test
  • Brugada syndrome 71 test
  • Brugada syndrome 81 test
  • Brugada syndrome 91 test
  • Congenital anomalies of kidney and urinary tract 11 test
  • Congenital anomalies of kidney and urinary tract 21 test
  • Congenital anomalies of kidney and urinary tract 31 test
  • Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay1 test
  • Coronary artery disease, autosomal dominant 21 test
  • Coronary artery disease, autosomal dominant, 11 test
  • Coronary heart disease, susceptibility to, 11 test
  • Coronary heart disease, susceptibility to, 21 test
  • Coronary heart disease, susceptibility to, 41 test
  • Coronary heart disease, susceptibility to, 51 test
  • Coronary heart disease, susceptibility to, 71 test
  • Coronary heart disease, susceptibility to, 81 test
  • Diabetes mellitus type 11 test
  • Dilated cardiomyopathy 1A1 test
  • Dilated cardiomyopathy 1AA1 test
  • Dilated cardiomyopathy 1KK1 test
  • Familial juvenile hyperuricemic nephropathy type 11 test
  • Finnish congenital nephrotic syndrome1 test
  • Focal segmental glomerulosclerosis 11 test
  • Focal segmental glomerulosclerosis 21 test
  • Focal segmental glomerulosclerosis 4, susceptibility to1 test
  • Focal segmental glomerulosclerosis 51 test
  • Focal segmental glomerulosclerosis and neurodevelopmental syndrome1 test
  • Hypercholesterolemia, autosomal dominant, 31 test
  • Hypercholesterolemia, autosomal dominant, type B1 test
  • Hypercholesterolemia, familial, 11 test
  • Hypercholesterolemia, familial, 41 test
  • Hypertrophic cardiomyopathy 251 test
  • Hypertrophic cardiomyopathy 261 test
  • Hypertrophic cardiomyopathy 41 test
  • IgA nephropathy, susceptibility to, 11 test
  • Immunoglobulin-mediated membranoproliferative glomerulonephritis1 test
  • Karyomegalic interstitial nephritis1 test
  • Left ventricular noncompaction 101 test
  • Left ventricular noncompaction 81 test
  • Long QT syndrome 11 test
  • Long QT syndrome 101 test
  • Long QT syndrome 111 test
  • Long QT syndrome 121 test
  • Long QT syndrome 131 test
  • Long QT syndrome 141 test
  • Long QT syndrome 151 test
  • Long QT syndrome 161 test
  • Long QT syndrome 21 test
  • Long QT syndrome 31 test
  • Long QT syndrome 51 test
  • Long QT syndrome 61 test
  • Long qt syndrome 81 test
  • Long QT syndrome 91 test
  • Maturity onset diabetes mellitus in young1 test
  • Maturity-onset diabetes of the young type 11 test
  • Maturity-onset diabetes of the young type 101 test
  • Maturity-onset diabetes of the young type 111 test
  • Maturity-onset diabetes of the young type 131 test
  • Maturity-onset diabetes of the young type 21 test
  • Maturity-onset diabetes of the young type 31 test
  • Maturity-onset diabetes of the young type 41 test
  • Maturity-onset diabetes of the young type 71 test
  • Maturity-onset diabetes of the young type 81 test
  • Membranoproliferative glomerulonephritis, X-linked1 test
  • Membranous nephropathy, susceptibility to1 test
  • Microvascular complications of diabetes, susceptibility to, 12 tests
  • Microvascular complications of diabetes, susceptibility to, 21 test
  • Microvascular complications of diabetes, susceptibility to, 31 test
  • Nephropathy, chronic tubulointerstitial1 test
  • Nephrotic syndrome 151 test
  • Nephrotic syndrome, type 21 test
  • Nephrotic syndrome, type 231 test
  • Renal cysts and diabetes syndrome2 tests
  • Renal tubular dysgenesis of genetic origin1 test
  • Short QT syndrome type 11 test
  • Short QT syndrome type 21 test
  • Short QT syndrome type 31 test
  • Systemic lupus erythematosus1 test
  • Systemic lupus erythematosus 171 test
  • Tubulointerstitial kidney disease, autosomal dominant, 21 test
  • Type 2 diabetes mellitus1 test
  • Vasculitis due to ADA2 deficiency1 test
  • Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Custom Sequence Analysis
  • Data Storage and Backup
  • Genetic counseling
  • Result interpretation
  • Whole Exome Sequencing

Participation in external programs

Standardization programs

  • Other

Data exchange Programs

  • Other

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.